Therefore, the H19 lncRNA may be used as apredictive biomarker for CAD, but the significance ofH19 lncRNA expression levels needs to be investigatedmore thoroughly in further studies using a larger samplein order to be considered as a novel biomarker for CAD. The gene discussed is H19; the disease is coronary artery disorder.